Foundational xenograft work identified a CD44+/CD24+/ESA+ CSC subpopulation with robust tumor-initiating capacity and self-renewal; as few as ~100 cells formed tumors and showed elevated Sonic Hedgehog expression, establishing CSC linkage to developmental signaling and tumor initiation in vivo [151,152]. The gene discussed is CD24; the disease is neoplasm.